FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZIGAKIBART
异名/同义词90401
ANTI-A PROLIFERATION-INDUCING LIGAND MONOCLONAL ANTIBODY BION-1301
ANTI-APRIL MONOCLONAL ANTIBODY BION-1301
ANTI-TNFSF13 MONOCLONAL ANTIBODY BION-1301
BION 1301 [WHO-DD]
BION1301
BION-1301
C90401
C-90401
IMMUNOGLOBULIN G4 (229-PROLINE), ANTI-(HUMAN PROLIFERATION-INDUCING LIGAND PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL BION-1301 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BION-1301 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TNFSF13 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 13, APRIL, CD256)), HUMANIZED MONOCLONAL ANTIBODY
ZIGAKIBART
ZIGAKIBART [INN]
ZIGAKIBART [USAN]
ZIGAKIBART [WHO-DD]
CAS登记号2642175-46-8
物质唯一标识(Unique Ingredient Identifier)WM18Z62RTI
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System